Skip to main content
. 2024 Mar 15;11:1366113. doi: 10.3389/fmolb.2024.1366113

TABLE 1.

Expression patterns of CENP-E proteins in multiple cancers.

Cancer types Type Level Functions of CENP-E Loss-of-function phenotypes References
Ovarian cancer Gene + Stimulates cell proliferation, migration, and epithelial-mesenchymal transition Obscure Ju et al., 2009; Li et al., 2020
Prostate cancer Protein + A novel biomarker and therapeutic target for the treatment of castration-resistant prostate cancer Inhibition of cell growth Liang et al. (2017)
Melanoma Protein + Regulation of chromosome segregation; tumorigenesis Obscure Uzdensky et al. (2014)
Neuroblastoma Gene + Stimulates tumor progression; a potential target. Inhibition of cell growth; mitotic arrest Balamuth et al. (2010)
Synovial sarcoma + A novel target for sarcoma diagnosis and prognosis Obscure Yao et al. (2021)
Retinoblastoma Gene + A novel biomarker; correlated with the invasive behaviors Obscure Shi et al. (2021)
Medulloblastoma + A potential therapeutic target. Activation of TP53 or TP73 and cell death signaling pathways Iegiani et al. (2021)
Breast cancer Gene + Associated with poor prognosis; increased JQ1 sensitivity Obscure Kung et al., 2014; Tian et al., 2021
Esophageal cancer mRNA + Associated with poor overall survival of patients with adenocarcinoma; a novel biomarker and target. Obscure Zhu et al. (2019)
Lung adenocarcinoma mRNA& Protein + Promotes the proliferation of LUAD cells Inhibition of cell proliferation Shan et al. (2019)
Non-small-cell lung cancer mRNA + Involved in the occurrence and development of NSCLC. Obscure Ma et al., 2019; Hao and Qu, 2019
Glioma mRNA + A novel biomarker and potential therapeutic target. Obscure Qi et al. (2020)
Hepatocellular carcinoma mRNA&Protein - A tumor suppressor; associated with the prognosis of HCC; a potential biomarker or therapeutic target. Aneuploidy Liu et al., 2009; He et al., 2020; Liang et al., 2021
Acute lymphoblastic leukemia mRNA +/− A tumor suppressor and oncogene Obscure Jiménez-Ávila et al. (2018)

Note: Lung adenocarcinoma, LUAD; Non-small-cell lung cancer, NSCLC; hepatocellular carcinoma, HCC; +, high expression level; -, low expression level.